Skip to main content
. 2021 Nov 18;300:114366. doi: 10.1016/j.jviromet.2021.114366

Table 1.

Diagnostic performance statistics of the Coris BioConcept COVID-19 Ag Respi-Strip test compared to the RealStar SARS-CoV-2 RT-PCR kit 1.0 assay obtained from the initial evaluation of 52 samples and the two-week real-life screening of 294 samples.

Coris-Ag diagnostic performance statisticsa Initial evaluation (15-min reading) (n = 52) Coris-Ag: 15-min readingb (n = 294) Coris-Ag: 30-min readingb (n = 294) Period 1c(n = 158) Period 2c(n = 136)
True positive 8 16 19 16 3
True negative 41 252 252 131 121
False positive 0 0 0 0 0
False negative 3 26 23 11 12
Sensitivity (%) 72.0 38.1 45.2 59.3 20.0
Specificity (%) 100 100 100 100 100
PPV (%) 100 100 100 100 100
NPV (%) 93.0 90.6 91.6 92.2 91.0
Positivity rate of RT-PCR (%)d 22.6 14.3 14.3 17.1 11.0
Positivity rate of Coris-Agd(%) 15.4 5.4 6.5 10.1 2.2
Coris-Ag accuracye(%) 94.2 91.2 92.2 93.0 91.2

PPV = positive predictive value and NPV = negative predictive value.

Accuracy = (true positive + true negative/true positive + false negative + true negative + false positive).

a

Performance statistics of Coris-Ag were calculated for both 15- and 30-min readings and for Periods 1 and 2.

b

The 15-min and 30-min reading data were of all the 294 patients over the two weekly periods.

c

Periods 1 and 2 data were based on the 30-min readings.

d

Positivity rates indicated for RT-PCR and Coris Ag were for the period of the initial evaluation (column 2), either the whole two weeks (columns 3 and 4) or for each Periods 1 and 2 separately (columns 5 and 6).

e

Accuracy: overall probability that a patient will be correctly classified.